Contact
 

New Lines of Attack in H.I.V. Prevention

The hottest news in AIDS in the last year was the partial success in a South African clinical trial of a microbicide.  Read the full New York Times article by Donald McNeil regarding the promise of microbicides upcoming PrEP results here.

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account